美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=NEOSTIGMINE METHYLSULFATE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
NEOSTIGMINE METHYLSULFATE 212968 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2019/10/16 2019/10/16 GLAND PHARMA LTD Prescription
NEOSTIGMINE METHYLSULFATE 212804 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2021/04/05 2021/04/05 MEITHEAL Prescription
NEOSTIGMINE METHYLSULFATE 212804 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2021/04/05 2021/04/05 MEITHEAL Prescription
NEOSTIGMINE METHYLSULFATE 213074 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2021/04/20 2021/04/20 CAPLIN Prescription
NEOSTIGMINE METHYLSULFATE 213074 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2021/04/20 2021/04/20 CAPLIN Prescription
NEOSTIGMINE METHYLSULFATE 210652 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2021/10/01 2021/10/01 ADAPTIS Prescription
NEOSTIGMINE METHYLSULFATE 210652 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2021/10/01 2021/10/01 ADAPTIS Prescription
NEOSTIGMINE METHYLSULFATE 216291 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 3MG/3ML (1MG/ML) No No 2022/07/06 2022/07/06 DR REDDYS Prescription
NEOSTIGMINE METHYLSULFATE 216206 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 3MG/3ML (1MG/ML) No No 2022/07/13 2022/07/13 HIKMA Prescription
NEOSTIGMINE METHYLSULFATE 212627 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2022/11/03 2022/11/03 UMEDICA Prescription
NEOSTIGMINE METHYLSULFATE 212627 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2022/11/03 2022/11/03 UMEDICA Prescription
NEOSTIGMINE METHYLSULFATE 216542 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2023/02/17 2023/02/17 SAGENT PHARMS INC Prescription
NEOSTIGMINE METHYLSULFATE 216542 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2023/02/17 2023/02/17 SAGENT PHARMS INC Prescription
NEOSTIGMINE METHYLSULFATE 213244 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2023/11/02 2023/11/02 EUGIA PHARMA Discontinued
NEOSTIGMINE METHYLSULFATE 213244 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2023/11/02 2023/11/02 EUGIA PHARMA Discontinued
NEOSTIGMINE METHYLSULFATE 213244 003 ANDA NEOSTIGMINE METHYLSULFATE INJECTABLE;INJECTION 5MG/10ML(0.5MG/ML) No No 2023/11/02 -- EUGIA PHARMA Prescription
NEOSTIGMINE METHYLSULFATE 213244 004 ANDA NEOSTIGMINE METHYLSULFATE INJECTABLE;INJECTION 10MG/10ML(1MG/ML) No No 2023/11/02 -- EUGIA PHARMA Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database